A group of scientists from a biotechnology startup known as R3 Bio have created multi-organ biological platforms know as ...

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” ...

R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Boston biotech firm R3 BIO is developing lab-grown organ systems called "bodyoids" with investors hoping the technology could ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

The National Institutes of Health announced last week that it will no longer issue funding calls for grant proposals that rely solely on animal testing. Moving forward, all such calls must also ...

Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...

Sponsors will now be able to submit preclinical toxicology data using virtual animal controls instead of a standard animal ...

Animal welfare and animal rights groups are praising the Trump administration’s moves away from animal testing for the development of pharmaceuticals as well as for medical and other research. They ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...